Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cell death assays for neurodegenerative disease drug discovery
Jeremy W. Linsley, Terry Reisine, Steven Finkbeiner
Expert Opinion on Drug Discovery (2019) Vol. 14, Iss. 9, pp. 901-913
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Roadmap to Cytotoxicity: Exploring Assays and Mechanisms
Kirtivardhan Singh Shekhawat, Prateek Bhatia, Kartik Bhatnagar, et al.
Assay and Drug Development Technologies (2025)
Closed Access | Times Cited: 2
Cell models for Alzheimer’s and Parkinson’s disease: At the interface of biology and drug discovery
Sandra Cetin, Damijan Knez, Stanislav Gobec, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 149, pp. 112924-112924
Open Access | Times Cited: 42
Rapid iPSC inclusionopathy models shed light on formation, consequence, and molecular subtype of α-synuclein inclusions
Isabel Lam, Alain Ndayisaba, Amanda J. Lewis, et al.
Neuron (2024) Vol. 112, Iss. 17, pp. 2886-2909.e16
Open Access | Times Cited: 10
Perineuronal net deglycosylation associates with tauopathy‐induced gliosis and neurodegeneration
Aric F. Logsdon, Brian Foresi, Shannon J. Hu, et al.
Journal of Neurochemistry (2024)
Open Access | Times Cited: 9
Potential of Therapeutic Small Molecules in Apoptosis Regulation in the Treatment of Neurodegenerative Diseases: An Updated Review
Hamad Ghaleb Dailah
Molecules (2022) Vol. 27, Iss. 21, pp. 7207-7207
Open Access | Times Cited: 25
Mechanistic Insights, Treatment Paradigms, and Clinical Progress in Neurological Disorders: Current and Future Prospects
Saad Alkahtani, Norah S. AL–Johani, Saud Alarifi
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1340-1340
Open Access | Times Cited: 14
The advancing role of fluorogens with AIE characteristics in drug screening
Jiawei You, Yu Ma, Hang Song, et al.
TrAC Trends in Analytical Chemistry (2024) Vol. 180, pp. 117886-117886
Closed Access | Times Cited: 5
Genetically encoded cell-death indicators (GEDI) to detect an early irreversible commitment to neurodegeneration
Jeremy W. Linsley, Kevan Shah, Nicholas A. Castello, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 31
Koumine ameliorates neuroinflammation by regulating microglia polarization via activation of Nrf2/HO-1 pathway
Lin Wang, Yingying Ding, Ya-qi Wu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115608-115608
Open Access | Times Cited: 12
The roles and mechanisms of CDGSH iron-sulfur domain 1 in kainic acid-induced mitochondrial iron overload, dysfunction and neuronal damage
Jing Wang, Shuo Li, Haidong Xu, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 187, pp. 118067-118067
Closed Access
Huntington’s disease iPSC models—using human patient cells to understand the pathology caused by expanded CAG repeats
Julia Kaye, Terry Reisine, Steven Finkbeiner
Faculty Reviews (2022) Vol. 11
Open Access | Times Cited: 17
Three dimensional and four dimensional live imaging to study mechanisms of progressive neurodegeneration
Jeremy W. Linsley, Terry Reisine, Steven Finkbeiner
Journal of Biological Chemistry (2024) Vol. 300, Iss. 7, pp. 107433-107433
Open Access | Times Cited: 3
NeuroLINCS Proteomics: Defining human-derived iPSC proteomes and protein signatures of pluripotency
Andrea Matlock, Vineet Vaibhav, Ronald J. Holewinski, et al.
Scientific Data (2023) Vol. 10, Iss. 1
Open Access | Times Cited: 7
(Bio)analytical approaches for investigating the role of selenium in preventing neurological disorders and neurotoxicity induced by environmental neurotoxicants: As, Cd, and Hg
Beatriz Gómez-Gómez, Tamara Fernández-Bautista, Yolanda Madrid
TrAC Trends in Analytical Chemistry (2024) Vol. 174, pp. 117661-117661
Open Access | Times Cited: 2
Cell viability and drug evaluation biosensing system based on disposable AuNPs/MWCNT nanocomposite modified screen-printed electrode for exocytosis dopamine detection
Mengmeng Liu, Fengfeng Zhang, Hui Liu, et al.
Talanta (2022) Vol. 254, pp. 124118-124118
Closed Access | Times Cited: 10
Superhuman cell death detection with biomarker-optimized neural networks
Jeremy W. Linsley, Drew Linsley, Josh Lamstein, et al.
Science Advances (2021) Vol. 7, Iss. 50
Open Access | Times Cited: 14
Perspective of 3D culture in medicine: transforming disease research and therapeutic applications
Chan Hum Park, Jung Ho Park, Yong Joon Suh
Frontiers in Bioengineering and Biotechnology (2024) Vol. 12
Open Access | Times Cited: 1
Rapid iPSC inclusionopathy models shed light on formation, consequence and molecular subtype of α-synuclein inclusions
Isabel Lam, Alain Ndayisaba, Amanda J. Lewis, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 7
Human iPS Cell-Derived Patient Tissues and 3D Cell Culture Part 1: Target Identification and Lead Optimization
Richard M. Eglen, Terry Reisine
SLAS TECHNOLOGY (2018) Vol. 24, Iss. 1, pp. 3-17
Open Access | Times Cited: 10
The Potential of Edible and Medicinal Resource Polysaccharides for Prevention and Treatment of Neurodegenerative Diseases
Qingxia Gan, Yugang Ding, Maoyao Peng, et al.
Biomolecules (2023) Vol. 13, Iss. 5, pp. 873-873
Open Access | Times Cited: 3
The outcome and burden of Chinese patients with neurodegenerative diseases: A 10‐year clinical feature study
LI Gui-hua, Peng Li, Lin Lu, et al.
International Journal of Clinical Practice (2020) Vol. 74, Iss. 9
Open Access | Times Cited: 6
Design, Synthesis and Biological Evaluation of Novel (E)‐Hydroxystyryl Aralkyl Sulfones as Neuroprotective Agents
Ying Chen, Yameng Hao, Qian Liu, et al.
ChemistrySelect (2020) Vol. 5, Iss. 21, pp. 6268-6273
Closed Access | Times Cited: 4
Screening and Structure–Activity Relationship of D2AAK1 Derivatives for Potential Application in the Treatment of Neurodegenerative Diseases
Oliwia Koszła, Przemysław Sołek, Piotr Stępnicki, et al.
Molecules (2022) Vol. 27, Iss. 7, pp. 2239-2239
Open Access | Times Cited: 2
Fluorescently labeled nuclear morphology is highly informative of neurotoxicity
Shijie Wang, Jeremy W. Linsley, Drew Linsley, et al.
Frontiers in Toxicology (2022) Vol. 4
Open Access | Times Cited: 2
Genetically encoded cell-death indicators (GEDI) to detect an early irreversible commitment to neurodegeneration
Jeremy W. Linsley, Kevan Shah, Nicholas A. Castello, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2019)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top